Associazioni Terapeutiche Nel Carcinoma Della Prostata ( 1 )

Ablin R. J. : Immunological studies of normal, benign and malignant human prostate tissue. Cancer, 29; 1570 (1972).

Ablin R. J. , Gonder M. J. , Soanes W. A. : Evolution of cell-bound antiprostatic antibodies after multiple cryotherapy of carcinoma of the prostate. Cryobiology, 11; 218 (1974).

Aboulker P. : Problèmes diagnostiques et thérapeutiques posés par le cancer de la prostate. J. de Radiol. Electrol., 55; 795 (1974).

Adler A. , Burger H. , Davis I. , Dulmanis A. , Hudson B. , Sarfaty G. , Straffon W. : Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy. Brit. Med. J., 28; 1 (1968).

Aiken C. E. , Dhom G. , Kopper B. : Verlaufskontrolle nach Hochvolttherapie des Prostatakarzinom. Urologe A, 16; 272 (1977).

Alyea E. P. , Dees J. E. , Glenn J. F. : An aggressive approach to prostatic cancer. J. Urol., 118; 211 (1977).

Asano M. , Kauraki S. , Sekiguki E. , Tasaka T. : Inhibition of prostatic growth in rabbits with antiovine prolactin serum. J. Urol 106; 248 (1971)

Bagshaw M. A. : Definite radiotherapy in carcinoma of the prostate. J.A.M.A., 210; 326 (1969).

Bartsch W. , Horst H. J. , Becker H. , Nehse G. : Sex hormone binding globulin binding capacity, testosterone, 5-alfa-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment. Acta Endocrinol., 85; 650 (1977).

Barzell W. , Bean M. A. , Hilaris B. S. , Whitmore W. F. Jr. : Prostatic adenocarcinoma: relationship of grade and local extent to the pattern of metastases. J. Urol., 118; 278 (1977).

Bates H R. , Thornton J. L. : Carcinoma of prostatic ducts. Amer. J. Clin. Pathol., 45; 96 (1966).

Blackard C. E. , Doe R. T. , Mellinger G. T. , Byar D. P. : Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer, 26; 249 (1970).

Bono A. V. : Protocollo di trattamento per il carcinoma prostatico. Urologia, 46; 762 (1977).

Bonucci De Matteis A. : Correlation between histological types and prognosis of prostatic carcinoma. In: Hormonal therapy of prostatic cancer, pag. 23–34, Ed. Cofese, Palermo 1975.

Boxer R. J. , Kaufman J. J. , Goodwin W. E. : Radical prostatectomy for carcinoma of the prostate: 1951–1976. A review od 329 patients. J. Urol., 208; 117 (1977).

Boynes A. R. , Griffiths K. , Pierrepoint C.G. , Peeling W. B. : Prolactin and the prostate. In: Normal and abnormal growth of the prostate. Goland M. ed., Charles C. Thomas Publ., Springfield, Illinois 1975.

Bracci U. , Di Silverio F. : Il nostro attuale orientamento nella terapia del carcinoma della prostata. Atti 16° Congr. Soc. it. Urol., vol. 2°, 207 (1973).

Byar D. P. , Mostofi F. K. : Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies examined by the step-section technique. Cancer, 30; 5 (1972).

Carlton C. E. , Hudgins P. T. , Guerriero W. G. , Scott R. : Radiotherapy in the management of stage C carcinoma of the prostate. J. Urol., 206; 116 (1976).

Catalona W. J. , Kadmon D. , Martin S. A. : Surgical considerations in treatment of intraductal carcinoma of the prostate. J. Urol. 120; 259 (1978).

Catalona W. J. , Chretien P. B. , Trahan E. E. : Abnormalities of cell-mediated immunocompetence in G-U cancer. J. Urol., 111; 229 (1974).

Catalona W. J. , Scott W. W. : Carcinoma of the prostate: a review. J. Urol., 119; 1 (1978).

Choe B. K. , Pontes J. E. , Morrison M. K. , Rose N. R. : A double antibody radioimmunoassay for prostatic acid phosphatase. Arch. Androl., 1; 1 (1978).

Chu T. M. , Shukla S. K. , Mittelman A. O. : Comparative evaluation of serum acid phosphatase, urinary cholesterol and androgens in diagnosis of prostatic cancer. Urology 6; 291 (1975).

Clark P. , Houghton L. : Subcapsular orchidectomy for carcinoma of the prostate. Brit. J. Urol., 49; 419 (1977).

Concolino E. , Marocchi A. , Di Silverio F. , Liberti M. : Androgen receptors in human prostatic cancer: our experience with methyltrienolone. J. Ster. Bioch., 8; 1 (1977).

Conti C. , Sciarra F. , Sorcini G. : Androgen sources. In: Hormonal therapy of prostatic cancer, pag. 59–69. Ed. Cofese, Palermo 1975.

Correa R. J. , Gibbons R. P. , Cummings K. B. , Mason J. T. : Total prostatectomy for stage B carcinoma of prostate. J. Urol., 117; 328 (1977).

Culp O. S. : Radical prostatectomy in the treatment of prostatic cancer. Cancer, 111; 32 (1973).

Dana M. , Koskas Y. : Problèmes de la radiothérapie du cancer de la prostate. J. de Radiol. Electrol., 55; 806 (1974).

Del Regato J. A. : Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate. Radiology, 88; 761 (1967).

Del Regato J. A. : Cancer of the prostate. J.A.M.A, 235; 1727 (1976).

De Muelenaere G. F. , Sandison A. G. : Treatment of locally advanced prostatic carcinoma. Brit. J. Radiol., 49; 944 (1976).

De VereWhite R. , Paulson D. F. , Glenn J. F. : The clinical spectrum of prostate cancer. J. Urol., 117; 323 (1977).

De Wys W. D. : Perspective and overview. Sem. Oncol., 3; 189 (1976).

Di Silverio F. : Histological type of tumor and hormone dependence. In: Hormonal therapy of prostatic cancer, pag. 47–57. Ed. Cofese, Palermo 1975.

Di Silverio F. , Loberti M. , Petrone U. , Amicarelli A. : Impiego del ciproterone acetato per via parenterale. Urologia, 44; 789 (1977).

Dube V. E. , Farrow G. M. , Greene L. F. : Prostatic adenocarcinoma of ductal origin. Cancer, 32; 402 (1973).

Egle N. , Alwein J. E. : Postpuberal castration and prostatic carcinoma. Urology, 6; 471 (1975).

Egle N. , Spieler P. : Zytologische und hystologische Verlaufkontrollen beim Hochvoltbestrahlen Prostatakarzinom. Helv. Chir. Acta, 43; 337 (1976).

Farnsworth W. E. : Prolactin on adrogen mobilisation. In « Normal and abnormal growth of the prostate», Thomas Pubi, Springfield 1975.

Farnsworth W. E. , Gonder M. J. : Prolactin and prostatic cancer. Urology, 10; 33 (1977).

Ferrari P. , Talia B. , Tavoni F. , Piccinini G. C. : L'ultrasuonotomografia della prostata per via transrettale: nostre esperienze. Urologia, 45; 45 (1978).

Flocks R. H. , Kerr H. D. , Elkins H. , Culp D. : Treatment of carcinoma od the prostate by interstitial radiation with radioactive gold (Au¹⁹⁶): a preliminary report. J. Urol., 68; 510 (1952).

Flocks R. H. , Nelson C. M. K. , Boatman D. L. : Perineal cryosurgery for carcinoma of the prostate. J. Urol., 108; 933 (1972).

Fonzo D. , Sivieri R. , Servidore D. , Angeli A. : Assetto funzionale dell'asse ipotalamo-ipofiso-gonadico in soggetti transessuati durante trattamento con alte dosi di estrogeni. Atti Giornate Endocrinologiche Pisane, pag. 691, Pisa 1977.

Frick J. , Bartsch G. , Marberger H. : Plasma androgens and their metabolism. In: Hormonal therapy of prostatic cancer, pag. 79–88. Ed. Cofese, Palermo 1975.

Gittes R. F. , Chu T. M. : Detection and diagnosis of prostatic cancer. Sem. Oncol, 3; 123 (1976).

Giuliani L. , Pescatore D. , Natta G. : Prolattina nell'adenoma e nel cancro prostatico. Atti Convegno « Urologia e ormoni », pag. 387–392, Reggio Emilia 1977.

Grayhack J. T. : Pituitary factors influencing growth of the prostate. Nat. Cancer Inst. Monogr., 12; 189 (1963).

Greene L. F. , Malcuny J. J. , Varren M. M. , Dockerty M. B. : Primary transitional cell carcinoma of the prostate. J. Urol., 110; 235 (1973).

Golimbu M. , Schinella R. , Morales P. , Kurusu S. : Differences in pathological characteristics and prognosis of clinical A₂ prostatic cancer from A₁ and B disease. J. Urol., 119; 618 (1978).

Gupta R. K. , Schuster R. , Christian W. D. : Loss of isoantigens A.B.H. in prostate. Amer. J. Pathol., 70; 439 (1973).

Hafiez A. A. , Lloyd C. W. , Bartke W. : The role of prolactin in the regulation of testis function; the effects of prolactin and luteinizing hormone on the plasma levels of testosterone and androstenedione in hypophysectomised rats. J. Endocrinol, 52; 327 (1972).

Hammond G. L. , Kontturi M. , Maattala P. : Serum TSH, LH and prolactin in normal patients with prostatic disease. Clin. Endocrinol, 7; 129 (1977).

Hanash K. A. , Utz D. C. , Cook E. N. , Taylor W. F. , Titus J. L. : Carcinoma of the prostate: a 11 year follow-up. J. Urol., 107; 450 (1972).

Hanash K. A. , Carney J. A. , Kelalis P. P. : Metastatic tumors to testicle: routes of metastasis. J. Urol., 102; 465 (1969).

Harper M. E. , Fahmy A. R. , Pierrepoint C. G. : The effects of stilbestrol compound on DNA polymerase from human prostatic tissue. Steroids, 15; 89 (1970).

Hilaris B. S. , Whitmore W. F. Jr. , Batata M. A. , Grabstald H. : Radiation therapy and pelvic node dissection in the management of cancer of the prostate. Amer. J. Roentgenol., 121; 832 (1974).

Hill D. , Crews Q. E. , Walsh P. C. : Prostate carcinoma: radiation treatment of the primary and regional lymphatics. Cancer, 34; 156 (1974).

Hoisaeter P. A. : Studies on hormone-cytostatic complexes in the cytoplasm of rat prostatic gland. Invest. Urol., 12; 33 (1974).

Hoisaeter P. A. : Incorporation of ³H-thymidine and ¹⁴C-aminoacids into the ventral prostate after in vivo treatment with Estracyt and its oestrogen and cytostatic parts. Invest. Urol., 14; 85 (1976).

Jacobi G. H. , Sinterhauf K. , Kurth K.H. , Altwein J. E. : Bromocriptine and prostatic carcinoma: plasma kinetics, production and tissue uptake of ³H-testosterone in vivo. J. Urol., 119; 240 (1978).

Jewett H. J. : Editorial: prostatic cancer. J. Urol., 108; 829 (1972).

Jewett H. J. , Eggleston J. C. , Jawn D. H. : Radical prostatectomy in the management of carcinoma of the prostate; probable causes of some therapeutic failures. J. Urol., 107; 1034 (1972).

Jewett J. H. : The present status of radical prostatectomy for stages A and B prostatic cancer. Urol. Clin. N. Amer., 2; 105 (1975).

Johnson D. E. , Hogan J. M. , Ayala A. G. : Transitional cell carcinoma of the prostate. A clinical morphological study. Cancer, 29; 287 (1972).

Jordan W. P. , Blackhard C. E. , Byar D. P. : Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. South. Med. J., 70; 1411 (1977).

Kadohama N. , Kirdani R. Y. , Murphy G. P. , Sandberg A. A. : Estramustine phosphate; metabolic aspects related to its action in prostatic cancer. J. Urol., 119; 235 (1978).

Kastendieck H. : Beurteilung der Behandlungsergebnissen bei Prostatakarzinom. Dtsch. med. Wschr., 101; 571 (1976).

Khalifa NM. M. , Jarman W. D. : A study of 48 cases of incidental carcinoma of the prostate followed 10 years or longer. J. Urol., 116; 329 (1976).

Karpas C. M. , Moumgis B. : Primary transitional cell carcinoma of the prostate gland; possible relationship to periurethral ducts. J. Urol., 101; 201 (1969).

Khan R. , Turner B. , Edson M. , Dolan M. : Bone marrow acid phosphatase: another look. J. Urol., 117; 79 (1977).

Kirdani R. Y. , Mittelman A. , Murphy G. P. : Studies on phenolic steroids in human subjects. XVI - Fate of a nitrogen mustard of estradioI-17-B. J. Clin. Endocrinol. Metab., 41; 305 (1975).

Lasnitzki I. : The effect of prolactin on rat prostate glands in organ culture. In: Prolactin and carcinogenesis. Proceedings Fourth Tenovus Workshop. Boynes A. R. & Griffiths K. eds. Alpha Omega Alpha Publishing Co., Cardiff 1972.

Lasnitzki I. : The effect of Hormones on rat prostate epithelium in organ culture. In: Normal and Abnormal Growth of the Prostate. Goland N. ed. Charles C. Thomas Publ., Springfield, Illinois 1975.

Loening S. A. , Schmidt J. D. , Brown R. C. , Hawtrey C. E. , Fallon B. , Culp D. A. : A comparison between lymphangiography and pelvic node dissection in the staging of prostatic cancer. J. Urol., 117; 752 (1977).

Logerfo P. , Krupey J. , Hansen H. J. : Demonstration of an antigen common to several varieties of neoplasia. N. Engl. J. Med., 285; 138 (1971).

Liao S. , Howell D. K. , Chang T. H. : Action of a non-steroidal antiandrogen flutamide on the receptor binding and nuclear retention on 5-alfa-DHT in rat ventral prostate. Endocrinology, 94; 1205 (1974).

Magrini G. , Ebiner J. R. , Buckhardt P. , Felber J. P. : Study on the relationship between plasma prolactin levels and androgen metabolism in man. J. Clin. Endocrinol. Metab., 43; 944 (1976).

Manandhar M. S. , Thomas J. A. : Effect of prolactin on the metabolism of androgens by the rat ventral prostate gland in vitro. Invest. Urol., 14; 20 (1976).

Mainwaring W. I. P. : Androgen receptors. Some aspects of the aetiology and biochemistry of prostatic cancer. Griffith & Pierrepoint Publ., Cardiff 1976.

Martelli A. , Soli M. , Bercovich E. , Reggiani A. , Rusconi R. , Grilli S. , Galli M. C. : I recettori ormonali nel carcinoma prostatico. Atti Convegno « Urologia e ormoni », Pag. 111–114, Reggio Emilia 1977.

Martinez-Pineiro J. A. , Ruiz F. , Hidalgo L. , Muntanola P. : La respuesta crio-imunològica en el cancer prostàtico. Acta Urol. Españ., 2; 23 (1978).

McCullough D. L. , McLaughlin A. P. , Gittes R. F. : Morbidity of pelvic lymphadenectomy and radical prostatectomy for prostatic cancer. J. Urol., 117; 206 (1977).

McGowan D. G. : Radiation therapy in the management of localised carcinoma of the prostate. Cancer, 8; 39 (1977).

Melicow M. M. , Pachter M. R. M. : Endometrial carcinoma of prostatic utricle (uterus masculinus). Cancer, 20; 1715 (1973).

Mertes J. , Niccol C. S. : Adenohypophysis: prolactin. Ann. Rev. Physiol., 28; 57 (1966).

Michigan S. , Catalona W. J. : Ureteral obstruction from prostatic carcinoma; response to endocrine and radiation therapy. J. Urol., 118; 733 (1977).

Mittelman A. , Seligman A. M. : Drug development for carcinoma of the prostate. Sem. Oncol., 3; 171 (1976).

Mostofi F. K. : Problems of grading carcinoma of prostate. Sem. Oncol., 3; 161 (1976).

Nachtsheim D. A. , McCaninch J. W. , Stutzman R E. , Goebel J. L. : Latent residual tumor following external radiotherapy for prostate adenocarcinoma. J. Urol., 120; 132 (1978).

Nagel R. , Koelln C. P. : Treatment of advanced carcinoma of the prostate with estramustine phosphate. Brit. J. Urol., 49; 37 (1977).

Neri R. O. , Monahan H. : Effects of a novel non steroidal antiandrogen on canine prostatic hyperplasia. Invest. Urol., 10; 123 (1972).

Neri R O. , Florance K. , Koziol P. , Van Cleave S. : A biological profile of a non steroidal antiandrogen SCH 13521. Endocrinology, 91; 427 (1972).

Nesbit R. M. , Baum W. C. : Endocrine control of prostatic carcinoma; clinical and statistical survey of 1818 cases. J.A.M.A., 13; 131 (1950).

Nichols R. T. , Barry J. M. , Hodges C. V. : The morbidity of radical prostatectomy for multifocal stage I prostatic carcinoma. J. Urol., 117; 83 (1977).

Nicholson T. C. , Richie J. P. : Pelvic lymphadenectomy for stage B₁ adenocarcinoma of the prostate; justified or not? J. Urol., 117; 199 (1977).

O'Conor V. J. , Chiang S. P. , Grayhack J. T. : Is subcapsular orchiectomy a definitive procedure? Studies on hormone excretion before and after orchiectomy. J. Urol., 89; 236 (1963).

Resnick M. I. , Grayhack J. T. : Treatment of stage IV carcinoma of the prostate. Urol. Clin. N. Amer., 2; 141 (1975).

Resnick M. I. , Willard J. W. , Boyce W. H. : Ultrasonic evaluation of the prostatic nodule. J. Urol., 120; 86 (1978).

Reynoso G. , Chu T. M. , Holyoke D. : Carcinoembryonic antigen in patients with different cancers. J.A.M.A., 220; 361 (1972).

Rhamy R. K. , Buchanan R. D. , Spalding M. J. : Intraductal carcinoma of the prostate gland. J. Urol., 109; 457 (1973).

Rhamy R. K. , %ilson S. K. , Caldwell W. L. : Biopsy-proved tumor following definitive radiation for resectable carcinoma of the prostate. J. Urol., 107; 627 (1972).

Rigondet G. , Le Pivert P. : La cryochirurgie dans le traitement du cancer prostatique. J. d'Urol., 83; 132 (1977).

Robinson M. R. G. : The effect of hormonal therapy of prostatic cancer. In: Hormonal therapy of prostatic cancer, pag. 139–150, Ed. Cofese, Palermo 1975.

Robinson M. R. G. , Nakhla L. S. , Shearer R. , Trott P. , Rigley C. C. : Lymphocyte transformation in carcinoma of the prostate. Proc. 16° Congr. Int. Soc. Urol., Amsterdam, 2; 1177 (1973).

Oliver J. A. , Elhihaly M. M. , Belitsky P. : LDH isoenzymes in benign and malignant prostatic tissue. The LDH V/I ratio as an index of malignancy. Cancer, 25; 863 (1970).

Pannuti F. , Saccani F. , Piana E. , Becchi G. , Pollutri E. : Proposta di un protocollo di trattamento del cancro prostatico in fase avanzata. Conv. « Urologia e ormoni », pag. 171–175, Reggio Emilia 1975.

Perez C. A. , Bauer W. , Garza R. , Royce R. K. : Radiation therapy in the definitive treatment of localized carcinoma of the prostate. Cancer, 40; 1425 (1977).

Pistenma D. A. , Ray G. R. , Bagshaw M. A. : The role of megavoltage radiation therapy in the treatment of prostatic carcinoma. Sem. Oncol., 3; 115 (1976).

Picchino A. , Guido A. , Di Rienzo U. , Bruno L. , Cirillo-Marucco F. : L'estramustinfosfato nel trattamento del carcinoma della prostata insensibile agli estrogeni. Urologia, 45; 236 (1978).

Pontes J. E. , Choe B. K. , Rose N. R. , Pierce J. M. Jr. : Bone marrow acid phosphatase in staging of prostatic cancer: how reliable is it? J. Urol., 119; 772 (1978).

Ray G. R. , Cassady J. R. , Bagshaw M. A. : Definitive radiation therapy of carcinoma on the prostate. A report on 15 year experience. Radiology, 106; 409 (1973).

Roy A. V. , Brower M. E. , Hayden J. E. : Sodium thymophtalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum. Clin. Chem., 17; 1093 (1971).

Rubenstein A. B. , Rubnitz M. E. : Transitional cell carcinoma of the prostate. Cancer, 24; 543 (1969).

Sadoughi N. , Razvi M. , Bush I. , Ablin R. , Guinan P. : Cancer of the prostate; relief of bone pain with levo-dopa. Urology, 4; 107 (1974).

Saglam S. , Wilson C. B. , Seymour R. J. : Indications for hypofisectomy in diabetic retinopathy and cancer of the breast and prostate. Calif. Med., 113; 1 (1970).

Salzstein S. L. , McLaughlin A. P. : Clinicopathological features of unsuspected regional lymph node metastases in prostatic adenocarcinoma. Cancer, 40; 1212 (1977).

Sandberg A. A. , Rosenthal H. , Mittelmen A. , Murphy G. P. : Prostatic cancer; transcortin levels during treatment with estramustine phosphate. Urology, 6; 17 (1975).

Sanford E. J. , Drago J. R. , Rohner T. J. Jr. , Santen R. , Lipton A. : Aminogluthetumide medical adrenalectomy for advanced prostatic carcinoma. J. Urol., 115; 170 (1976).

Savatovsky I. , Court B. , Dutreiz J. : Traitement de l'adénocarcinome de la prostate per télé-irradiation. J. d'Urol., 103; 83 (1977).

Schroeder F. H. , Belt E. : Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J. Urol., 114; 257 (1973).

Schubert G. E. : Hormone dependency and histological types of tumors. In: Hormonal therapy of prostatic cancer, pag. 43–45. Ed. Cofese, Palermo 1975.

Scott W. W. , Boyd H. L. : Hormone control and surgery: conversion into resectable lesion. J.A.M.A., 210; 1070 (1969).

Segal S. J. , Marberger H. , Flocks R. H. : Tissue distribution of stilbestrol diphosphate: concentration in prostatic tissue. J. Urol., 81; 474 (1959).

Shain S. A. , Boesel R. W. : Human prostate steroid hormone receptor quantitation: current methodology and possible utility as a clinical discriminant in carcinoma. Invest. Urol., 16; 169 (1978).

Shearer R. J. , Hendry W. F. , Sommerville I. F. : Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer. Brit. J. Urol., 45; 668 (1973).

Smart I. G. : The use of ³²P in the treatemnt of severe pain from bone metastases of carcinoma of the prostate. Brit. J. Urol., 37; 139 (1965).

Smith P. H. , Robinson M. R. G. , Cooper E. H. : Carcinoma of the prostate: a focal point for divergent disciplines. Europ. J. Cancer., 12; 937 (1976).

Spaulding J. T. , Whitmore W. F. Jr. : Extended total excision of prostatic adenocarcinoma. J. Urol., 120; 188 (1978).

Spellman M. C. , Castellino R. A. , Ray G. R. : An evaluation of lymphography in localised carcinoma of the prostate. Radiology, 125; 637 (1977).

Squassabia A. , Angelini L. , Sigillino I. : Ecotomografia della regione pelvica per via transrettale. Arch. it. Urol., 50; 191 (1978).

Sufrin G. , Kirdani R. Y. , Sandberg A. : Estrogen binding and estrogen receptors in the prostate, (cit. da Mittelman). Surg. Forum, 26; 584 (1975).

Tomlinson R. L. , Currie D. P. , Boyce W. H. : Radical prostatectomy: palliation for stage C carcinoma of the prostate. J. Urol., 117; 85 (1977).

Tong G. C. K. , Finkelstein P. : The treatment of prostatic bone metastases with parathormone and radio-active phosphorus. J. Urol., 109; 71 (1973).

Trisch G. L. , Shukla S. K. , Mittelman A. : Estracyt (NSC 89199) as a subshrate for phosphatases in human serum. Invest. Urol., 12; 38 (1974).

Tsuya A. , Kawai T. , Fukushima S. , Shida K. , Shimazaki J. , Matsumoto K. , Seto T. : Radiotherapy combined with hormone therapy for prostate cancer. Strahlentherapie, 148; 24 (1974).

Ullman A. S. , Ross O. A. : Hyperplasia, atypism and carcinoma in situ in prostatic periurethral glands. Amer. J. Clin. Pathol., 47; 497 (1967).

Valenti G. , Banchini A. , Stagni G. , Potenzoni D. : Sulla possibile correlazione fra prolattina e neoplasie prostatiche. Atti Convegno « Urologia e ormoni », pag. 347–354, Reggio Emilia 1977.

Veenema R. J. , Gursel E. O. , Romas N. , Wechsler M. , Lattimer J. K. : Bone marrow acid phosphatase: prognostic value in patients undergoing radical prostatectomy. J. Urol., 117; 81 (1977).

Veenema R. J. , Gursel E. O. , Lattimer J. K. : Radical retropubic prostatectomy for cancer: a 20-year experience. J. Urol., 117; 330 (1977).

Völter D. : Morphological parameters evaluating the effects of hormonal therapy. In: Hormonal therapy of prostatic cancer, pag. 155–158. Ed. Cofese. Palermo 1975.

Walsh P. C. : Chapter on « Physiologic basis for hormonal therapy in carcinoma of the prostate ». Urol. Clin. N. Amer., 2; 125 (1975).

Walsh P. C. , Siiteri P. K. : Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate. J. Urol., 114; 254 (1975).

Whitmore W. F. , Hilaris B. , Grabstald H. , Batata M. : Implantation of ¹²⁵I in prostatic cancer. Surg. Clin. N. Amer., 54; 887 (1974).

Williams G. , Castro J. E. : The diagnostic and prognostic significance of delayed hypersensitivity skin testing in patients with urological cancer. Brit. J. Urol., 47; 97 (1975).

Young B. W. , Lagios M. D. : Endometrial (papillary) carcinoma of the prostatic utricle — response to orchiectomy — a case report. Cancer, 32; 1293 (1973).

Zaloudek C. , Williams J. W. , Kempson R. L. : « Endometrial » adenocarcinoma of the prostate. A distinctive tumor of probable prostatic duct origin. Cancer, 37; 2255 (1976).

Ziegler H. : Efficacy and disavantages of antiandrogenes. In: Hormonal therapy of prostatic cancer, pag. 151–154. Ed. Cofese, Palermo 1975.